Tigchelaar W, Yu H, de Jong AM, van Gilst WH, van der Harst P, Westenbrink BD, de Boer RA, Silljé HH. Loss of mitochondrial exo/endonuclease EXOG affects mitochondrial respiration and induces ROS-mediated cardiomyocyte hypertrophy. Am J Physiol Cell Physiol 308: C155-C163, 2015. First published November 5, 2014 doi:10.1152/ajpcell.00227.2014.-Recently, a locus at the mitochondrial exo/endonuclease EXOG gene, which has been implicated in mitochondrial DNA repair, was associated with cardiac function. The function of EXOG in cardiomyocytes is still elusive. Here we investigated the role of EXOG in mitochondrial function and hypertrophy in cardiomyocytes. Depletion of EXOG in primary neonatal rat ventricular cardiomyocytes (NRVCs) induced a marked increase in cardiomyocyte hypertrophy. Depletion of EXOG, however, did not result in loss of mitochondrial DNA integrity. Although EXOG depletion did not induce fetal gene expression and common hypertrophy pathways were not activated, a clear increase in ribosomal S6 phosphorylation was observed, which readily explains increased protein synthesis. With the use of a Seahorse flux analyzer, it was shown that the mitochondrial oxidative consumption rate (OCR) was increased 2.4-fold in EXOG-depleted NRVCs. Moreover, ATP-linked OCR was 5.2-fold higher. This increase was not explained by mitochondrial biogenesis or alterations in mitochondrial membrane potential. Western blotting confirmed normal levels of the oxidative phosphorylation (OXPHOS) complexes. The increased OCR was accompanied by a 5.4-fold increase in mitochondrial ROS levels. These increased ROS levels could be normalized with specific mitochondrial ROS scavengers (MitoTEMPO, mnSOD). Remarkably, scavenging of excess ROS strongly attenuated the hypertrophic response. In conclusion, loss of EXOG affects normal mitochondrial function resulting in increased mitochondrial respiration, excess ROS production, and cardiomyocyte hypertrophy.
cardiomyocytes; hypertrophy; mitochondria; mitochondrial respiration; ROS THE HEART IS ONE OF THE MOST energy-consuming organs in the human body. This energy, in the form of ATP, is used to maintain proper contractile function and is mainly produced by cellular respiration, in particular by oxidative phosphorylation (OXPHOS) in the mitochondria. There is a strict correlation between energy production (supply) and energy utilization (demand). As the heart has limited energy storage capacity, ATP-generating systems must respond proportionally to fluctuations in demand. This energetic status of the heart is a delicate balance and is often disturbed in cardiovascular diseases, including heart failure.
As a byproduct of oxidative phosphorylation, the mitochondria produce reactive oxygen species (ROS). Low levels of ROS may be protective (7, 23) and affect signaling pathways that may stimulate growth (5) . However, an imbalance between ROS production and the normal cellular antioxidant defense system will lead to oxidative stress and potentially in DNA damage (10) . Therefore, cells have developed sophisticated DNA repair mechanisms.
EndonucleaseG-like-1 (EXOG), a nuclear encoded mitochondrial DNA/RNA exo/endonuclease, is one of the proteins that has been implicated in the repair of mitochondrial DNA (mtDNA) damage (22) . Specifically, EXOG depletion has been reported to induce apoptosis due to mitochondrial dysfunction in a range of human cell lines, including HeLa and MCF7 cells. Also, in a myoblast cell line EXOG has been shown important for maintaining mtDNA integrity, but, surprisingly, this was not true for myotubes, implicating that EXOG is not essential in all cell types (21) . Probably other mitochondrial exo/endonucleases, like FEN-1 and DNA2, are sufficient for maintaining DNA damage integrity in these cells (20) .
The function of EXOG in cardiomyocytes has not been investigated. It is interesting to note, however, that in a genome-wide association study EXOG was shown to be associated with QRS duration, which is a risk factor for mortality, sudden death, and heart failure (19) . Moreover, loss of EndoG, another mitochondrial endonuclease with high sequence similarity to EXOG (2) , has recently been shown to induce cardiac hypertrophy (15) . Although EndoG was originally believed to be a main regulator of caspase-independent regulation of DNA fragmentation and apoptosis (1, 17) , these new results suggest additional functions of this enzyme. Based on the current EXOG knowledge, and in analogy to EndoG, we hypothesized that EXOG would have additional functions in (cardio)myocytes.
The aim of the present study was thus to investigate the function of EXOG in cardiomyocytes, in particular its potential role in hypertrophy next to its role in mtDNA repair.
METHODS
Isolation and culturing of primary cardiomyocytes. Primary neonatal rat ventricular cardiomyocytes (NRVCs) were isolated from neonatal rats of 1-3 days old, as previously described (12, 14) . The use of animals for these studies was in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The study was submitted to and approved by the Committee for Animal Experiments of the University of Groningen. NRVCs were grown in DMEM supplemented with 5% fetal calf serum (FCS) and penicillin-streptomycin (100 U/ml-100 g/ml). NRVCs were infected with recombinant adenovirus particles [multiplicity of infection (MOI) of 50] 24 h after isolation and serum starved in DMEM with penicillin-streptomycin (100 U/ml-100 g/ml) the next day. Stimulation of cells with 50 M phenylephrine (PE) was done for 24 h after 24 h of starvation. A schematic depiction of the culturing procedure is shown in Fig. 1A .
All media and supplements were purchased from Sigma-Aldrich Chemie (Zwijndrecht, The Netherlands).
Adenoviral constructs generation and infection. Adenoviral constructs were generated with the ViraPower adenoviral expression system from Invitrogen (Bleiswijk, The Netherlands) using a specific siRNA oligo pair (forward: GATCCC GGGTGGAACCTGACGAT-TATTCAAGAGATAATCGTCAGGTTCCACCCTTTTTGGAAA; reverse: AGCTTTTCCAAAAAGGGTGGAACCTGACGATTATCTCT-TGAAT AATCGTCAGGTTCCACCCGG) against the rat EXOG gene. The annealed primers were cloned into a pENTR4 vector containing a H1-promoter and a GFP marker gene. Recombinant adenovirus was generated as previously described (13) . For adenoviral infections, neonatal ventricular cardiomyocytes were infected with an MOI of 50.
Quantitative real-time PCR. Total RNA was isolated using a nucleospin RNA II kit (Bioke; Leiden, The Netherlands), and cDNA was synthesized using QuantiTect Reverse Transcriptional kit (Qiagen, Venlo, The Netherlands) following manufacturer's instructions. Relative gene expression was determined by quantitative real-time PCR (qRT-PCR) on the Bio-Rad CFX384 real-time system (Bio-Rad, Veenendaal, The Netherlands) using ABsolute QPCR SYBR Green mix (Thermo Scientific, Landsmeer, the Netherlands). Gene expressions were corrected for reference gene values (36B4) and expressed relative to the control group. Primer sequences can be found in Table 1 .
Western blot. Protein was isolated with RIPA buffer (50 mM Tris pH 8.0, 1% Nonidet P40, 0.5% deoxycholate, 0.1% SDS, and 150 mM NaCl) supplemented with 10 ul/ml phosphatase inhibitor cocktail 1 (Sigma-Aldrich), protease inhibitor cocktail (Roche Diagnostics, Indianapolis, IN), and 1 mM phenylmethylsulfonyl fluoride (PMSF; Roche Diagnostics). Protein concentrations were determined with a DC protein assay kit (Bio-Rad). Equal amounts of proteins were separated by SDS-PAGE, and proteins were transferred onto PVDF membranes. The following antibodies were used: anti-OXPHOS cocktail (MitoSciences, Eugene, OR), anti-EXOG, anti-pERK1/2 (Santa Cruz Biotechnology Dallas, TX), anti-tERK1/2 (Santa Cruz Biotechnology), anti-pAkt (Cell Signaling Technology, Danvers, MA), anti-tAkt (Cell Signaling Technology), anti-pS6 (Cell Signaling Technology), anti-tS6 (Cell Signaling Technology), and anti-GAPDH (Fitzgerald Industries International, North Acton, MA) at a dilution of 1:1,000. After incubation with horseradish peroxidase-conjugated Fig. 1 . Depletion of endonucleaseG-like-1 (EXOG) does not affect mitochondrial (mt)DNA integrity in neonatal cardiomyocytes. A: neonatal rat ventricular cardiomyocytes (NRVCs) were isolated and cultured according to the scheme. After 72 h of adenoviral infection, mRNA was isolated and protein lysates were prepared. B: by RT-PCR relative EXOG mRNA levels were determined and normalized to 36B4 (n ϭ 5). C: EXOG protein levels were determined by Western blotting and corrected for GAPDH expression (n ϭ 5). D: representative Western blot is shown. E: semilong run PCR was performed using primers specific for mtDNA fragments in the mitochondrial D-loop region to determine mtDNA damage (n ϭ 11). F: different concentrations of H2O2 were used to induce mtDNA damage, which was analyzed using a semilong run PCR. G: cell death was indirectly quantified by measuring lactate dehydrogenase (LDH) activity in cell culture medium (n ϭ 6 -8). A.U., arbitrary units. *P Ͻ 0.05, compared with control; N.S., not significant. secondary antibodies, signals were visualized with ECL and analyzed with densitometry (ImageQuant LAS4000; GE Healthcare Europe, Diegem, Belgium).
[ 3 H]leucine incorporation. Cells were grown in 12-well plates and 24 h after starvation l- [4,5- 3 H]leucine (1 Ci/ml; PerkinElmer) was added in either the presence or absence of 50 M PE. Cells were cultured for an additional 24 h and l- [4,5- 3 H]leucine incorporation was determined as previously described (12) .
Cell size measurement. NRVCs were grown on coverslips coated with laminin (Millipore, Amsterdam, The Netherlands). After adenoviral infection and serum starvation, cells were washed with PBS and fixed for 10 min with paraformaldehyde buffer at 4°C, followed by permeabilization with 0.5% TritonX for 5 min. Cells were incubated with monoclonal anti-␣-actinin antibody (Sigma-Aldrich) in 1% BSA/ PBS for 1 h at room temperature. Cells were washed and incubated for another hour with Alexa-555 secondary antibody (Invitrogen Life Technologies). Coverslips were mounted with mounting medium containing DAPI for counterstaining of the nuclei, slides were imaged using a TissueFAXs (AxioObserver Z1 microscope; Carl Zeiss, Jena, Germany), and cell size was determined by TissueQuest fluorescence analysis software.
DNA damage and mtDNA-to-nDNA ratio. Total DNA including mtDNA was extracted from cells using the DNA blood and tissue kit (Qiagen), and DNA purity and quantity were determined by spectroscopic analysis. The isolated DNA showed high purity (A 260/A280 Ͼ 1.8).
A semilong run quantitative real-time PCR was performed as described before (18) . The D-loop mitochondrial genomic region was targeted since this part of the mitochondrial genome is described to be the most susceptible to DNA damage (18) . To evaluate the DNA damage lesions in this specific region, two mtDNA fragments of different length were used ( Table 1 ). The PCR protocol included an incubation step at 95°C for 10 min, followed by 40 cycles of 10 s at 95°C, 10 s at 60°C, and 10 s 72°C (small fragments) or 50 s 72°C (long fragments), respectively. DNA from untreated samples was taken as a control. For the quantification of damage in the mtDNA, qRT-PCR analysis for the corresponding long and short fragments was performed.
To determine the ratio between mitochondrial and nuclear DNA, relative gene expression was determined by qRT-PCR on a Bio-Rad CFX384 real-time system using SYBR Green dye. Mitochondrial gene expressions were corrected for nuclear gene expression values, and the calculated values were expressed relative to the control group per experiment. Primer sequences are listed in Table 1 .
Lactate dehydrogenase activity. Oxidative stress-derived cytotoxicity was monitored by the lactate dehydrogenase (LDH) release assay. LDH activity was determined in cell culture medium using the Roche IFCC liquid assay on the modular analysis according to the manufacturer's instructions (Roche).
Seahorse mitochondrial flux analyses. To determine the oxidative consumption rate (OCR) in cardiomyocytes, a Seahorse metabolic flux analyzer (Seahorse Biosciences) was used as previously described (24) . Neonatal cardiomyocytes were seeded at a density of 100,000 cells/well in special Seahorse 24-well plates. Cells were adenoviral infected and treated as described above. One hour before initiation of measurements, medium was replaced with XF medium supplemented with 10 mM glucose or 1 mM pyruvate and incubated for 1 h in a CO 2 free 37°C incubator. The basal respiration of the cells was measured followed by injection of oligomycin (ATP synthase inhibitor; 1 M) to measure the ATP linked OCR. The uncoupler carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP; 0.5 M) was used to determine maximal respiration. Before the experiments a titration curve to determine optimal FCCP concentration was performed and revealed that 0.5 M FCCP was the optimal concentration. Rotenone (1 M) and antimycin A (1 M), to inhibit complex I and III, respectively, were injected to determine the nonmitochondrial respiration. The mitochondrial OCR was calculated by extracting the nonmitochondrial respiration from the basal respiration. In each plate the same treatment was performed in triplicate or quadruple and each experiment was performed at least three times. OCR was corrected for the amount of total protein in each well.
Citrate synthase assay and ATP concentration. Whole cell citrate synthase activity was measured using an enzyme assay kit (SigmaAldrich) according to the manufacturer's instructions. Cell lysates were prepared using the CelLytic M Cell Lysis Reagent, and protein concentrations were measured with a DC protein assay kit (Bio-Rad). Eight micrograms of protein were combined with acetyl coenzyme A, 5,5=-dithiobis-(2-nitrobenzoic acid), and assay buffer in a 96-well plate. The reaction was initiated by adding oxaloacetate into the mixture and total activity was measured. Absorbance was measured at 412 nm using a spectrophotometer following a kinetic program. Triplicate measurements were performed on each sample, and five independent samples were measured for each group.
ATP concentrations were measured with a bioluminescence assay kit CLS II (Roche, Mannheim, Germany) following manufacturer's instructions with modifications. In short, cells were lysed by adding 1.5% TCA with NaF (1 mM) and subsequently diluted in 1 M Tris buffer (pH 8.0) containing NaF (1 mM). Reaction was initiated by dispensing Luciferase reagent simultaneously in all wells. Luminescence was recorded with SynergyH4 Hybrid Reader (BioTek).
Determination of mitochondrial membrane potential and ROS production. Mitochondrial membrane potential (⌬⌿m) was assessed by tetramethylrhodamine ethyl ester (TMRE), as described before (24) . In brief, cells were seeded at a density of 40.000 cells/well in black 96-well plates and cultured as described above. TMRE (100 nM) was added and incubated for 20 min at 37°C. Cells were subsequently washed with 0.2% BSA in PBS, and fluorescence was measured at 575 nm with a SynergyH4 Hybrid Reader (BioTek). As a control, FCCP (1 M) was used to eliminate mitochondrial membrane potential.
Mitochondrial ROS production was determined using MitoSOX red mitochondrial superoxide indicator (Molecular Life Technologies, Bleiswijk, The Netherlands) as described before (24) . Briefly, cells were plated in 96-well plates and treated as described above. Cells were subsequently incubated with MitoSOX (5 M) in KRPH buffer (20 mM HEPES, 5 mM KH 2PO4, 1 mM MgSO4, 1 mM CaCl2, 136 mM NaCl, and 4.7 mM KCl pH 7.4) for 10 min at 37°C and thereafter washed three times with the same buffer. Fluorescence was measured using excitation/emission maxima of 510/580 nm with a SynergyH4 Hybrid Reader (BioTek). For both assays, each experiment was measured in quadruplicate and five independent experiments were performed. 
RESULTS
Depletion of EXOG does not affect mtDNA integrity in neonatal cardiomyocytes. NRVCs were cultured and treated according to the scheme in Fig. 1A . Using an adenoviral EXOG siRNA construct we tested the effect of EXOG depletion/loss of function on NRVCs. Figure 1 , B-D, shows that the expression of EXOG was substantially repressed both at the mRNA and protein level after 72 h of adenoviral infection. Silencing of EXOG did not increase the level of mtDNA damage compared with control cells (Fig. 1E) , as determined by a previously described PCR method (18) . DNA-damaged lesions were readily detected in H 2 O 2 -treated NRVCs, validating this method (Fig. 1F) . Also, cell viability was not affected by silencing of EXOG, as LDH levels in cell culture medium were not increased in EXOG-silenced cells compared with control cells (Fig. 1G) and cell numbers remained similar in both control and EXOG-depleted cultures during the time of the experiment (data not shown). Thus under these conditions, EXOG was not essential for maintaining mtDNA integrity.
EXOG silencing induces hypertrophy in neonatal cardiomyocytes. Since the EXOG locus has been linked to cardiovascular disease (19) and Endog has been shown to be involved in cardiomyocyte growth (15), we next investigated whether EXOG could induce hypertrophy in NRVCs. A significant increase in both protein synthesis and cell size was observed after silencing of EXOG (Fig. 2, A-C) . The increase in cell size was comparable to PE-induced hypertrophy. In contrast to PE-stimulated cells, the expression of the pathological stretch marker ANP was not increased in EXOG-depleted NRVCs (Fig. 2D) . We also investigated main signaling pathways involved in hypertrophy, including ERK1/2 and Akt, but did not observe activation of these pathways after silencing of EXOG (Fig. 2, E and F) . In contrast, we observed a strong increase in phosphorylation of ribosomal protein S6 (rpS6), a protein involved in protein elongation and synthesis (Fig. 2, E  and F) . Thus EXOG depletion activates protein synthesis, resulting in hypertrophy of NRVCs, but this is not mediated via common pathways.
EXOG depletion increases mitochondrial OCR. Based on the mitochondrial localization of EXOG and its effect on cell growth, we decided to investigate changes in mitochondrial function, in particular mitochondrial respiration. With the use of a seahorse metabolic flux analyzer, the cellular OCR was determined. Total oxygen consumption rates are shown in Fig.  3A . The measured increase in respiration was determined to be 3 H]leucine. This was performed for control, EXOG-depleted, and phenylephrine (PE)-treated cells, and fold changes are shown relative to the control (n ϭ 8 -10). B: cell size was measured to determine cellular hypertrophy. Cardiomyocytes were specifically stained with an ␣-actinin antibody, and nuclei were counterstained with DAPI. Cell surface areas of at least 1,000 cells/experiment were determined, and fold changes compared with the control were determined (n ϭ 6 -9). C: representative microscopy images are shown. D: RT-PCR analysis was performed to determine ANP gene expression. ANP mRNA expression was normalized to 36B4 expression and relative levels are shown (n ϭ 9). E: Western blot quantification of main signal transduction pathways involved in hypertrophy. Phosphorylated proteins (P-ERK1/2, P-Akt, and P-S6) were quantified in relation to the total amounts of the respective proteins (T-ERK1/2, T-Akt, and T-S6). Levels in EXOG-depleted cells are shown relative to control cells (dashed line; n ϭ 5). F: representative Western blots are shown. *P Ͻ 0.05, compared with control. mitochondrial specific, since it was blocked by antimycin A/rotenone (A/R). Based on these data the mitochondrial specific respiration was calculated (A/R OCR levels subtracted from total OCR levels). This revealed that silencing of EXOG increased mitochondrial OCR with 2.4-fold compared with control cells (OCR 4.8 and 11.6 pmol O 2 ·min Ϫ1 ·g protein Ϫ1 , respectively; Fig. 3B ). The OCR was corrected for protein concentration to correct for possible effects of hypertrophy on respiration. When corrected only for cell numbers, the difference in mitochondrial respiration between control and EXOGdepleted cells was even more pronounced (3.1-fold increase in EXOG-depleted cells). By adding the ATP synthase inhibitor oligomycin to the cells, the ATP-linked OCR could be determined. As shown in Fig. 3C , ATP-linked respiration was increased in EXOG-depleted cells by more than fivefold. The total ATP concentration in EXOG-depleted cells was only marginally increased (Fig. 3D) , indicating that ATP utilization was also increased. Although not significant, an apparent increase in maximal respiration, induced with the uncoupler FCCP, and the reserve capacity, which is the difference between maximal respiration and basal cellular respiration, were observed (Fig. 3, E and F) . Similar results were obtained using pyruvate as a substrate, indicating that the findings are not explained by increased glycolysis (data not shown). In summary, loss of EXOG function increased mitochondrial respiration in cardiomyocytes.
EXOG depletion does not affect expression levels of electron transport chain proteins or mitochondrial biosynthesis.
The elevated mitochondrial respiration in EXOG-depleted NRVCs could be a result of increased mitochondrial biogenesis or the result of intrinsic changes in the mitochondria. The ratio between mtDNA and nucDNA, an established measure of mitochondrial biogenesis, was similar between control and EXOG-depleted cells (Fig. 4A) . In addition, citrate synthase activity, an independent measure of mitochondrial biogenesis, was also not altered (Fig. 4B) .
As shown in Fig. 4 , C and D, no expression differences between the different complexes of the electron transport chain (ETC) were observed in an OXPHOS Western blot. Although this does not rule out that the activity of these complexes might be altered by posttranslational modifications, it at least shows that changes in expression levels cannot account for the increased OCR.
Loss of EXOG induces ROS production. Changes in mitochondrial function can result in the formation of ROS. We therefore analyzed ROS production in mitochondria using Mito-SOX. As shown in Fig. 5A , ROS levels in mitochondria were significantly elevated in EXOG-depleted cells. Only a limited increase in fluorescence was observed with dihydroethidium (DHE), which is expected since it lacks the mitochondrial localization signal, which is present in MitoSOX (Fig. 5B) . Another, cytoplasmic specific, ROS sensor, CellROX, did not show in- ; n ϭ 7). *P Ͻ 0.05, compared with control; N.S., not significant. creased fluorescence in EXOG-depleted cells, further confirming the mitochondrial specificity (data not shown).
Because an increase in mitochondrial ROS production could be the result of increased membrane potential, TMRE was used to determine mitochondrial membrane potential. No difference in mitochondrial membrane potential between control and EXOG-depleted cells was seen (Fig. 5C ). To determine specificity, we analysed the membrane potential in FCCP-treated cells, which resulted as expected in a marked decrease in mitochondrial membrane potential. Together, this shows that EXOG depletion results in an altered mitochondrial flux and an increase in ROS production.
Scavenging ROS attenuates hypertrophy in EXOG-depleted cells without significantly affecting mitochondrial metabolism.
Previous studies have shown that increased ROS levels could induce hypertrophy development (10) . To investigate whether reducing ROS in EXOG-depleted cells could attenuate hypertrophy, the mitochondrial ROS scavenger MitoTEMPO was used.
ROS levels were reduced to baseline levels with this scavenger (Fig. 5D) . A similar reduction was obtained with the ROS scavenger mnSOD. In contrast, addition of a cellular scavenger, catalase, did not reduce MitoSOX fluorescence, indicating that mitochondrial ROS is responsible for this effect (data not shown). Interestingly, as shown in Fig. 5E, [ 3 H]leucine incorporation was significantly lower in MitoTEMPO-treated EXOG-depleted cells compared with EXOG-depleted cells without this ROS scavenger. The cell size of EXOG-depleted cells treated with MitoTEMPO was also determined. In line with the reduction in protein synthesis, an attenuation of cell size in MitoTEMPO-treated EXOGdepleted cells was observed, as shown in Fig. 5F . This suggests that hypertrophy development in EXOG-depleted cells is predominantly mediated by increased ROS levels, as schematically depicted in Fig. 6 .
MitoTEMPO did not significantly affect EXOG depletionmediated OCR increase (Fig. 5G) . This indicates that the increased OCR is predominantly ROS and hypertrophy independent and directly a result of EXOG depletion. These findings are schematically depicted in Fig. 6 .
DISCUSSION
In this study, we show that depletion of EXOG, a protein implicated in mitochondrial DNA repair, did not affect mtDNA integrity in neonatal cardiomyocytes. Surprisingly, EXOG depletion resulted in a marked induction of hypertrophy in these cells. EXOG depletion is not associated with increased activity of hypertrophic common signaling pathways or mitochondrial biogenesis. Instead, EXOG depletion markedly increased mitochondrial respiration, which was accompanied by an increase in mitochondrial ROS emissions. Scavenging of mitochondrial ROS attenuated hypertrophy development in EXOG-depleted cells, suggesting that hypertrophy induced by diminished EXOG levels is dependent on mitochondrial ROS. Together Fig. 4 . Increase in mitochondrial respiration is not a result of mitochondrial biogenesis. A: mitochondrial DNA (CYTB)-to-nuclear DNA (TRPM-2) ratio (mtDNA/nDNA) was determined by RT-PCR on DNA samples from control infected cells and EXOG-depleted cells. No statistical significant difference was observed between the groups (n ϭ 5). B: citrate synthase activity, a measure of the amount of mitochondria, was determined in cellular lysates. No significant differences were observed between the EXOG-depleted cells compared with control cells (n ϭ 5). C and D: Western blotting using an OXPHOS antibody panel, detecting components of the different electron transport chain complex (ETC), was used to determine ETC levels. All levels were normalized for GAPDH levels. No significant differences ETCs were observed between the control group and EXOG-depleted NRVCs as shown by a representative Western blot and quantification (n ϭ 3). TNB, 5,5=-dithiobis-(2-nitrobenzoic acid).
these findings indicate that EXOG has a pivotal role in the control of mitochondrial respiration and ROS emissions and has functions beyond mtDNA repair. In addition, the current study provides a clear precedent for the role of reverse mitochondrial signaling in the control of critical cellular responses such as hypertrophy.
Depletion of EXOG did not result in mtDNA damage in neonatal cardiomyocytes. This does not exclude that under specific stress conditions or upon prolonged depletion DNA damage might increase in EXOG-depleted NRVCs. In Hela cells, a similar time period of EXOG depletion was sufficient to cause extensive damage. This indicates that cardiomyocytes are either more resistant to ROS-mediated mtDNA damage or that other pathways operate to maintain proper mtDNA integrity. This is in line with Szczesny et al. (21) who showed that mtDNA of proliferating myoblasts was more sensitive to ROS induced damage compared with non proliferating myotubes. Thus the importance of EXOG in mtDNA repair appears to be cell type specific. Perhaps other mitochondrial exo/endonucleases, like FEN-1 and DNA2, can take over EXOG function or are sufficient for maintaining mtDNA integrity in these cells (20) . Alternatively, EXOG might be more important in maintaining mtDNA integrity during DNA replication in proliferating cells, rather than damage repair per se. Such a function has recently been shown for another mitochondrial exonuclease MGME1 (9) and may explain why proliferating cells are more prone to EXOG depletion.
Even though EXOG does not appear to be essential for maintaining mtDNA integrity in cardiomyocytes, it is highly expressed in these cells. This begs the question why EXOG is Fig. 5 . Scavenging reactive oxygen species ROS attenuates hypertrophy in EXOG-depleted cells without significantly affecting mitochondrial metabolism. A: mitochondrial specific ROS production was measured by labeling cells with the MitoSOX fluorophore and MitoSOX specific fluorescence was determined. In EXOG-depleted cells a significant increase in ROS production was observed compared with control cells (n ϭ 9). B: cellular ROS levels were measure using dihydroethidium (DHE). A slight, but not significant, increase in fluorescence level was observed in EXOG-silenced cells (n ϭ 4). C: mitochondrial membrane potential, measured by cellular labeling with the fluorophore tetramethylrhodamine ethyl ester (TMRE), was not different between groups. As a control, the depolarizing compound FCCP was added, which resulted in a significant reduction of TMRE fluorescence (n ϭ 5). D: increase in EXOG depletion induced mitochondrial ROS levels could be effectively scavenged with the exogenous added mitochondrial specific scavenger MitoTEMPO. ROS was measured with MitoSOX, as in A (n ϭ 6 -8). E: [ 3 H]leucine incorporation in EXOG-silenced cells with and without MitoTEMPO. The increase in EXOG-mediated hypertrophy could be attenuated with MitoTEMPO (n ϭ 6). F: cardiomyocytes treated with or without MitoTEMPO were specifically stained with an ␣-actinin antibody and nuclei were counterstained with DAPI and cell surface area was measured (n ϭ 6). G: mitochondrial OCR was measured in control and EXOG-depleted cells, with or without treatment with MitoTEMPO (n ϭ 5). *P Ͻ 0.05, compared with control; #P Ͻ 0.05, compared with EXOG-silenced NRVCs control. present in these cells and, in analogy to Endog, whether this exonuclease has additional functions beyond DNA cleavage. Interestingly, mitochondrial OCR was strongly increased in EXOG-depleted cardiomyocytes. This was independent of mitochondrial biogenesis and mitochondrial membrane potential and suggests an intrinsic change in mitochondrial function. So far we did not observe changes in ETC complex levels or ATP synthase, but we cannot exclude that posttranslational modifications or stability of particular subunits of the ETC has been altered. This would require more in depth proteomic investigations.
Increased mitochondrial flux could both be beneficial and detrimental, depending on cellular needs and substrate supply. ATP levels remained normal in EXOG-depleted cells, and hence no detrimental imbalance between ATP production and requirement was observed. Increased metabolic flux is also strongly linked to increased ROS production, which is one of the main mechanisms behind cellular aging (4, 7). Indeed, we did observe increased mitochondrial ROS production in EXOG-depleted cells. Although MitoSOX and other DHEbased fluorescent dyes are sensitive sensors for superoxide other oxidants can also affect their fluorescent properties (25) . An increase in MitoSOX fluorescence could also indicate an impairment in the mitochondrial antioxidant system. Although we cannot fully exclude this possibility, no changes in mRNA levels of components of the antioxidant systems (MnSOD, catalase) were observed (data not shown). Mitochondrial ROS production has been linked to hypertrophy development (6, 11) , and interestingly we observed hypertrophy in EXOGdepleted NRVCs as determined by increased protein synthesis and cell size surface area. We checked the main hypertrophic signaling pathways, including activation of the pathological ERK signaling pathway and the physiological AKT signaling pathway but, interestingly, did not observe activation of these pathways. Thus hypertrophy stimulation was not mediated via these canonical pathways. rpS6 phosphorylation was, however, strongly enhanced in EXOG-depleted cells. rpS6 directly controls protein translation and cellular growth and is a key cell size determination and hence would readily explain the observed hypertrophic effects (16) . Interestingly, we did not observe an increase in the pathological stress marker ANP, suggesting that these levels of ROS did not provoke a general stress response in these cells. This is in contrast to ENDOG depletion that resulted in ANP induction (15) , which was confirmed by us (our unpublished results) and shows that ENDOG and EXOG functions are distinct. Moreover, although increased ROS production and consequent hypertrophy development were observed in both EXOG-and ENDOG-depleted cells, the underlying mechanisms appear to be different. In ENDOG-depleted cells mitochondrial function and levels were impaired (15) , whereas in EXOG-depleted cells mitochondrial respiration was increased. At least for the latter case, we have shown here that scavenging of mitochondrial ROS attenuated hypertrophy development, indicating that ROS is an important driver of hypertrophy in EXOG-depleted cells. This may also be true for other mitochondrial proteins that can stimulate hypertrophy and supports the idea that mitochondrial ROS scavenging may have clinical applications to attenuate cardiac hypertrophy development (3, 4) .
This study was conducted with neonatal rat cardiomyocytes in vitro, and these results cannot be directly extrapolated to cardiomyocytes in the adult heart. Moreover, energy demand in these cells is limited, because these cardiomyocytes do not perform load-dependent contractions. Despite these limitations, neonatal rat cardiomyocytes are an established model to investigate cellular hypertrophy and these results clearly show that EXOG has mitochondrial functions beyond mtDNA repair in cardiomyocytes.
In conclusion, this study shows that EXOG depletion does not affect mtDNA integrity in neonatal cardiomyocytes. It does, however, affect mitochondrial OCR implicating that EXOG has additional mitochondrial functions. Interestingly, Here we showed that EXOG function is also involved in maintaining normal mitochondrial flux in cardiomyocytes (middle). Moreover, increased ROS production in EXOG-depleted cells can stimulate cardiomyocyte hypertrophy (right).
this resulted in increased ROS production and consequent hypertrophy development in neonatal cardiomyocytes.
